References
- 1. Centers for Disease Control and Prevention. Sexually Transmitted Diseases (STDs): CDC; 2020 [cited 2020. Available from: https://www.cdc.gov/std/statistics/default.htm.
- 2. European Centre for Disease Prevention and Control. Infographic: Sexually transmitted infections: a long-standing and ongoing threat for public health ECDC2020 [Available from: https://www.ecdc.europa.eu/en/publications-data/infographic-sexually-transmitted-infections-long-standing-and-ongoing-threat.
- 3. Dongya M, Wencheng X, Xiaobo M, Lu W. Transition mutations in 23S rRNA account for acquired resistance to macrolides in Ureaplasma urealyticum. Microb Drug Resist. 2008;14(3):183-6.10.1089/mdr.2008.081718707551
- 4. Xiao L, Crabb DM, Duffy LB, Paralanov V, Glass JI, Hamilos DL, et al. Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp. Int J Antimicrob Agents. 2011;37(4):377-9.10.1016/j.ijantimicag.2010.12.01221353494
- 5. Autobio diagnostics Co. LTD. Mycoplasma IES kit technical insert.
- 6. Waites KB, Bade DJ, Bebear C, Brown SD, Davidson MK, Duffy LB, et al. Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas; Approved Guideline. CLSI Standards: Guidelines for Health Care Excellence. Wayne (PA)2011.
- 7. Abdel Rahman SM, Hassan RA, Sakna NA. Antimicrobial susceptibility pattern of genital Mycoplasmas among a group of pregnant women. Alexandria Journal of Medicine. 2016;52(4):353-8.10.1016/j.ajme.2015.12.005